SUNPHARMA vs DIVISLAB vs TORNTPHARM vs LAURUSLABS: which stock is better?
Divi's Laboratories Limited (DIVISLAB) has the highest StockLens rating in this group at 8.0/10 (Excellent).
| Metric | SUNPHARMA | DIVISLAB | TORNTPHARM | LAURUSLABS |
|---|---|---|---|---|
| Overall rating | 6.4/10 (Average) | 8.0/10 (Excellent) | 5.6/10 (Average) | 7.3/10 (Good) |
| Long-term view | Good for long-term | Strong long-term candidate | Neutral (watchlist) | Good for long-term |
| Trade bias | Strong long | Strong long | Long bias | Strong long |
| Share price | ₹1,870.00 | ₹11,150.00 | ₹4,668.80 | ₹2,338.00 |
| Market cap | ₹4,48,676 Cr | ₹2,95,997 Cr | ₹1,77,586 Cr | ₹1,26,325 Cr |
| P/E | 40.9 | 88.0 | 78.9 | 94.4 |
| Return on equity | 13.1% | 20.1% | 15.7% | 24.0% |
| Debt / equity | 0.04 | 0.00 | 0.77 | 0.42 |
| Revenue growth (YoY) | +11.9% | +35.4% | +50.8% | +33.4% |
| 1-year return | +10.1% | +66.6% | +22.3% | +133.6% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.